Will tolerance become a clinical reality?

American Journal of the Medical Sciences

Volumn 313, Issue 5, 1997, Pages 310-314

  Aradhye, Shreeram ^a   Turka, Laurence A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Immunosuppression; T cells; Transplantation

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CELL ADHESION MOLECULE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; SYNTHETIC PEPTIDE;

ANTIGEN RECOGNITION; ARTICLE; BONE MARROW; CHIMERA; CLONAL ANERGY; HUMAN; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; THYMUS;

EID: 0030940817     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199705000-00011     Document Type: Article

References (40)

1. Blackman M, Kappler J, and Marrack P. The role of the T cell receptor in positive and negative selection of developing T cells. Science. 1990;248:1335-41.
2. Davis MM and Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature. 1988;334:395-402.
3. Sprent J, Gao EK and Webb SR. T cell reactivity to MHC molecules: Immunity versus tolerance. Science. 1990; 248:1357-63.
4. von Boehmer H and Kisielow P. Self-nonself discrimination by T cells. Science. 1990;248:1369-72.
5. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-62.
6. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G and Thompson CB. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993;74:597-608.
7. Nagata S and Golstein P. The Fas death factor. Science. 1995;267:1449-56.
8. Linsley PS and Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annual Review of Immunology. 1993;11:191-221.
9. Janeway CH and Bottomly K. Signals and Signs for Lymphocyte Responses. Cell. 1994;76:275-85.
10. Bluestone JA. New perspectives of CD28-B7-mediated T cell costimultion. Immunity. 1995;2:555-9.
11. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA and Coffman RL. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348.
12. Khoury SJ, Hancock WW and Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are differential upregulation of transforming growth factor-B and prostaglandin E expression in the brain. J Exp Med. 1992;176:1355-64.
13. Chen Y, Kuchroo VK, Inobe JI, Hafler DA and Weiner HL. Regulatory T cells clones induced by oral tolerance: Suppression of autoimmune encophalomyolitis. Science. 1994;265:1237-40.
14. Thomas TM, Carver FM, Cunningham RC, Olson LC and Thomas FT. Kidney allograft tolerance in primates without chronic immunosuppression - the role of veto cells. Transplantation. 1991;51:198-207.
15. Starzl TE, Demetris AJ, Murase N, Thomson AW, Trucco M and Ricordi C. Donor cell chimerism permitted by immunosuppressive drugs: A new view of organ transplantation. Immunol Today. 1993;14:326-32.
16. Sykes M and Sachs DH. Bone marrow transplantation as a means of inducing tolerance. Semin Immunol. 1990;2:401-17.
17. Ildstad ST and Sachs DH. Reconstitution with synergeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature. 1984; 307:168-70.
18. Thomas JM, Verbanc KM and Thomas FT. The veto mechanism in transplant tolerance. Transplantation Reviews. 1991;5:209-29.
19. Alexander JW, Babcock GB, First MR, Davies CB, Madden RL, Munda R, Penn I, Fidler JP, Cofer BR, Stephens G, Schroeder TJ, Hariharan S, Cardi M, Manzler A, Cohen L, Mendoza N, Clyne D and Giese F. The induction of immunologichyperesponsiveness by pre-operative donor-specific transfusions and cyclosporine in human cadaveric transplants. Transplantation. 1992;53:423-7.
20. Alexander JW, Davies CB, First MR, Cofer BR, Munda R, Madden RL, Hariharan S and Schroeder TJ. Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantation. Transplant Proc. 1993;25:485-7.
21. Barber WH, Mankin J, Laskow D, Deirhoi M, Julian B, Curtis J and Diethelm A. Long-term results of a controlled prospective study with transfusion of donor specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation. 1991;51:70-5.
22. Posselt AM, Barker CF, Tomaszewski JE, Markmann JF, Choti MA and Naji A. Induction of donor-specific unre- sponsiveness by intrathymine islet transplantation. Science. 1990;249:1293-5.
23. Remuzzi G, Rossini M, Imberti O and Perico N. Kidney graft survival in rats without immunosuppressants after intrathymic glomerular transplantation. Lancet. 1991;337: 750-2.
24. Remuzzi G, Perico N, Carpenter CB and Sayegh MH. The thymic way to transplantation tolerance. J Am Soc Nephrol. 1995;5:1639-46.
25. Khoury SJ, Sayegh MH, Gallon L, Hancock WW, Carpenter CB and Weiner HL. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalotigenie peptide. J Exp Med. 1993;178:559-66.
26. Nussenblatt RB, Whitecup SM, De Smet MD, Caspi RR, Kozhich AT, Weiner HL, Vistica B and Gery I. Intraocular Inflammatory Disease (Uveitis) and the Use of Oral Tolerance: A Status Report. Ann N Y Acad Sci. 1996;778:325-37.
27. Trentham DE. Evidence That Type II Collagen Feeding Can Induce a Durable Therapeutic Response in SoPatients with Rheumatoid Arthritis. Ann N Y Acad Sci. 1996; 778:306-14.
28. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson D and Hafler DA. Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple Sclerosis. Science. 1993;259:1321-4.
29. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA and Weiner HL. Effects of Oral Administration of Type II Collagen on Rheumatoid Arthritis. Science. 1993;261:1727-30.
30. Krensky AM and Clayberger C. The induction of tolerance to alloantigens using HLA-hased synthetic poptides. Current Opinion in Immunology. 1994;6:791-6.
31. Sayegh MH, Khoury SI, Hancock WW, Weiner HL and Carpenter CB. Induction of Immunity and Oral Tolerance with Polymorphic Class II Major Histocompatibility Complex Allopeptides in the Rat. Proc Natl Acad Sci U S A. 1992; 89:7762-6.
32. Wood KJ, Pearson TS, Darby C and Morris PJ. CD4: A potential target molecule for immunosuppressive therapy and tolerance induction. Transplant. 1991;5:150.
33. Soulillou JP. Relevant targets for therapy with monoclonal antibodies in allograft transplantation. Kidney International. 1994;46:540-53.
34. Morel P, Vincent C, Cordier G, Panage G, Carosella E and Revillard JP. Anti CD4 monoclonal antibody administration in renal transplanted patients. Clin Immunol Immunopathol. 1990;56:311.
35. Norman DJ, Bennet WM, Cobanoglu A, Hershberger R, Hosenpud JD, Meyer MM, Misti J, Ott G, Ratkovec R, Shihab F, Vrrow C and Barry JM. Use of OKT4A (a murine monoclonal anti-CD4 antibody) in human organ transplantation: Initial clinical experience. Transplant Proc. 1993;25:802.
36. Lin H, Bolling SF, Linsley PS, Wei R, Gordon D, Thompson CB and Turka LA. Long-Term Acceptance of Major Histocompatibility Complex Mismatched Cardiac Allografts Induced by CTLA4Ig Plus Donor-specific Transfusion. J. Exp Med. 1993;178:1801-6.
37. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ and Pearson TC. Longterm acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 1996;381:434-8.
38. Isobe M, Yagita H, Okumura K and Ihara A. Specific Acceptance of Cardiac Allograft After Treatment with Antibodies to ICAM-1 and LFA-1. Science. 1992;255:1125-7.
39. Le Mauff B, Hourmant M, Rougier JP, Hirn M, Dantal J, Baatard R, Cantarovich D, Jaques Y and Soulillou JP. Effect of anti-LFA1 (CD11a)0 monoclonal antibodies in acute rejection in human kidney transplantation. Transplantation. 1991;52:291.
40. Fischer A, Griscelli C, Blanche S, Le Deist F, Veber F, Lopez M, Delaage M, Olive D, Mawas C and Janossy G. Prevention of graft failure by an anti LFA-1 monoclonal antibody in HLA-mismatched bone marrow transplantation. Lancet. 1986;2:1058.